LEXICON PHARMACEUTICALS INC (LXRX)

US5288723027 - Common Stock

0.7717  -0.04 (-4.42%)

After market: 0.77 0 (-0.22%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to LXRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.18. This target is 571.45% above the current price.
LXRX was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LXRX.
In the previous month the buy percentage consensus was at a similar level.
LXRX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.771.414.085.1810.50 - 83.23% 428.70% 571.45% 1,260.63%
Up and Down Grades
Date Firm Action Rating
2024-11-13 Needham Reiterate Hold
2024-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-01 Needham Reiterate Hold
2024-11-01 HC Wainwright & Co. Maintains Buy -> Buy
2024-10-30 Needham Reiterate Hold
2024-10-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-27 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-21 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-21 HC Wainwright & Co. Reiterate Buy
2024-06-17 HC Wainwright & Co. Initiate Buy
2024-05-03 Needham Reiterate Hold
2024-04-30 Leerink Partners Initiate Outperform
2024-04-23 Needham Reiterate Hold
2024-04-11 Needham Reiterate Hold
2023-05-31 Citigroup Maintains Buy -> Buy
2023-05-30 Needham Maintains Hold
2023-03-07 Jefferies Initiate Hold
2022-08-12 Piper Sandler Initiate Overweight
2022-07-01 Citigroup Maintains Buy